epipen
FDA doesn’t OK nasal spray EpiPen alternative; Raleigh firm also has one under development
Federal regulators declined to approve a nasal spray from a San Diego company to treat severe allergic reactions late Tuesday, calling for more research on what would have been the first alternative to injections using devices such as an EpiPen. A Raleigh firm also has a nasal spray alternative under development.
Read More
Raleigh startup raises $17.5M, aims for FDA approval of nasal spray to counter strong allergic reactions
Bryn Pharma, which is developing a nasal spray to counteract life-threatening allergic reactions known as anaphylaxis, says it will move toward securing FDA approval for its product and plan to commercialize it after raising $17.5 million in new financing.
Read More
Raleigh life science firm Bryn Pharma raises $17.2M
A Raleigh-based life science company raised $17.2 million in a private equity offering, according to a securities filing.
Read More
